Past experience says that when the FDA has the will to use its regulatory power, it can shake whole industries. Companies like Juul should tread extremely carefully.
As a branded drug, Gleevec’s price increases were the target of criticism by oncologists, payers, and patients. Yet, its price was more reflective of value than many other cancer drugs. What is problematic is the fact that generic imatinib’s list price…
Mass shooters appear to injure and kill more people when the use semiautomatic rifles instead of handguns, other types of rifles, or shotguns, according to a new analysis in the Journal of The American Medical Association. But the research has signific…
The British company is growing its trove of patient data used to help healthcare providers remotely monitor vital signs to predict illness and disease.
Medicare ACOs saved U.S. taxpayers $1.84 billion from 2013 to 2015, a study commissioned by the National Association of ACOs says amid its policy battle with the Trump administration over value-based care.